Abstract
Proteolysis targeting chimeras (PROTACs) are bifunctional molecules that recruit an E3 ligase to a target protein to facilitate ubiquitination and subsequent degradation of that protein. While the field of targeted degraders is still relatively young, the potential for this modality to become a differentiated and therapeutic reality is strong, such that both academic and pharmaceutical institutions are now entering this interesting area of research. In this article, we describe a broadly applicable process for identifying degrader hits based on the serine/threonine kinase TANK-binding kinase 1 (TBK1) and have generalized the key structural elements associated with degradation activities. Compound 3i is a potent hit (TBK1 DC 50 = 12 nM, D max = 96%) with excellent selectivity against a related kinase IKKϵ, which was further used as a chemical tool to assess TBK1 as a target in mutant K-Ras cancer cells.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 583-598 |
| Number of pages | 16 |
| Journal | Journal of medicinal chemistry |
| Volume | 61 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 25 2018 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Drug Discovery